Translating promising research findings into effective therapies presents a formidable challenge. This complex endeavor is often plagued by hurdles, ranging from fundamental biological complexities to legal hurdles. Bridging this gap requires a multifaceted strategy that integrates rigorous preclinical research, collaborative alliances, and efficie